Highest-materiality recent filing
eHealth stockholders approve equity plan share increase, elect directors at 2026 annual meeting
Elected Class II directors Prama Bhatt (18.5M for) and Beth A. Brooke (17.5M for).
eHealth Q1 2026 revenue falls 22% to $88M; GAAP net loss $4.7M, adj. EBITDA $9M
Q1 total revenue $88.0M (-22% YoY); GAAP net loss $4.7M vs net income $2.0M in Q1 2025.
Director Andrea Brimmer will not stand for re-election at eHealth's 2026 annual meeting
Andrea Brimmer notified eHealth of her decision not to stand for re-election as director.
eHealth Q4 2025 revenue $326.2M (+4% YoY); adj. EBITDA $132.9M (+10%); commissions receivable $1.1B
Q4 GAAP net income $87.2M vs $97.5M YoY; FY 2025 GAAP net income $40.0M, up from $10.1M.
eHealth closes $125M asset-based revolver with Manulife | Comvest; repays $70M Blue Torch Loan
New $125M revolving credit facility matures Dec 2028; SOFR + 6.50% interest rate, lower than prior term loan.
eHealth raises FY2025 guidance after strong AEP; adj. EBITDA guided to $80-95M
Total revenue guidance raised to $540-560M from $525-565M; GAAP net income raised to $30-45M from $9-30M.
eHealth raises FY 2025 guidance, Q3 revenue down 8% to $53.9M, net loss improves
Q3 2025 revenue $53.9M, down 8% YoY; GAAP net loss $31.7M vs $42.5M loss in Q3 2024.
eHealth extends term loan maturity to January 2027, reaffirms capital structure objectives
Entered Third Amendment to Credit Agreement with Blue Torch Finance LLC; maturity extended to January 29, 2027.
eHealth board changes: Tolson resigns, Arden and Duke appointed
Aaron Tolson resigned from eHealth Board and all committees effective Sept 17, 2025; no disagreement cited.
eHealth Q2 revenue $60.8M (-8% YoY), GAAP net loss improves; raises FY2025 guidance
Q2 total revenue $60.8M, down 8% YoY; GAAP net loss $17.4M improved from $28.0M loss.
eHealth names Derrick Duke CEO; Fran Soistman to retire effective Sept 18, 2025
Derrick Duke, former CEO of Magellan Health, appointed CEO effective Sept 18, 2025; joins Aug 4 for transition.
eHealth CEO Fran Soistman extends term to Sept 30, 2025; receives $1M retention award
CEO Soistman will stay as CEO until successor appointed or Sept 30, 2025, then serve as Executive Advisor through Dec 31, 2025.
eHealth Q1 revenue $113.1M (+22% YoY); swings to GAAP net income $2.0M
GAAP net income $2.0M vs net loss $17.0M in Q1 2024; adjusted EBITDA $12.5M vs $(1.7)M.
eHealth reports record Q4: revenue $315.2M, net income $97.5M, adjusted EBITDA $121.3M
Q4 total revenue $315.2M (+27% YoY); GAAP net income $97.5M (+87%); adjusted EBITDA $121.3M (+74%).
eHealth raises FY2024 revenue guidance to $500-520M and Adjusted EBITDA to $40-55M after strong AEP
FY2024 revenue guidance raised to $500M-$520M (prior $470M-$495M); GAAP net income improved to $(12M)-$3M from $(36.5M)-$(22M).
eHealth Q3 revenue down 10% to $58.4M; GAAP net loss widens to $42.5M
Q3 total revenue $58.4M, down 10% YoY; positive net adjustment revenue fell from $12.2M to $1.2M.
eHealth extends credit facility maturity to Feb 2026, cuts interest margin by 50 bps
Maturity date extended from Feb 28, 2025 to Feb 27, 2026 on $70M outstanding term loans.
eHealth grants $750K cash & ~94K RSU retention awards to 3 executives on CEO transition
Three execs (John Dolan, Michelle Barbeau, Gavin Galimi) each receive $250K cash and 31,300 RSUs.
eHealth appoints Prama Bhatt to Board of Directors; effective Sept 24, 2024
Prama Bhatt appointed as Class II director, term expiring at 2026 annual meeting.
GAAP net loss $28.0M (19% increase YoY); Non-GAAP net loss improved 9% YoY.
eHealth stockholders approve 2024 Equity Plan and ESPP amendment, elect directors
Stockholders approved the 2024 Equity Incentive Plan authorizing up to 1,350,000 new shares plus up to 300,000 from prior plan.
eHealth CFO John Stelben to retire Aug 2024; CAO John Dolan appointed CFO
Stelben resigns effective Aug 30, 2024; will consult through Dec 2024 at $10,000/month.
eHealth Q1 revenue $93M (+26% YoY); Medicare Advantage members up 9%; adj EBITDA improves $11M
Q1 2024 revenue $93.0M (+26% YoY); Medicare Advantage approved members 65,750 (+9%).
eHealth Q4 revenue $247.7M (+26% YoY); GAAP net income $52.2M vs $20.7M
Q4 2023 total revenue $247.7M (+26% YoY); excluding positive net adjustment, up 25%.
eHealth Q4 preliminary revenue $241-249M; Medicare Advantage members +22% YoY
Q4 2023 total revenue expected $241M-$249M; FY2023 revenue $446M-$454M, in line with guidance.
eHealth COO Roman Rariy resigns effective Dec 31; CMO Barbeau promoted to CRO
COO and CTO Roman Rariy to depart Dec 31, 2023; resignation not due to any disagreement with company.
eHealth Q3 revenue up 21% to $64.7M; net loss narrows to $37M; AEP outlook positive
Q3 2023 revenue $64.7M (up 21% YoY); GAAP net loss $37.0M improved from $39.1M in Q3 2022.
Revenue $66.8M (+32% YoY); includes $18.7M positive net adjustment revenue from favorable persistency/commissions.
eHealth stockholders re-elect Brimmer and Brooke, ratify EY, approve say-on-pay
Andrea C. Brimmer and Beth A. Brooke elected as Class II directors with 18.9M and 20.0M votes for respectively.
eHealth Q1 revenue $73.7M (-30% YoY); net loss improves $12.9M to $(19.9)M
Revenue $73.7M, down 30% YoY from $105.3M; net loss $(19.9)M improved $12.9M.
eHealth reiterates 2023 annual guidance; comments on new CMS MA/Part D rule
Total revenue expected $420M-$440M; GAAP net loss $55M-$35M; adj. EBITDA $(15)M-$5M.
eHealth beats FY2022 guidance; Q4 net income $20.7M vs loss year ago
Q4 revenue $196.3M; GAAP net income $20.7M (10.5% margin) vs net loss $32.2M in Q4 2021.
eHealth director Randall Livingston will not stand for re-election at 2023 annual meeting
Livingston notified the company on Feb 3, 2023; his term expires at the 2023 annual meeting.
eHealth Q4 prelim rev $190-200M, FY rev $395-405M; narrower adjusted EBITDA loss vs guidance
Revenue for FY2022 expected $395-405M, above prior guidance of $375-395M.
eHealth amends bylaws to comply with universal proxy rules and DGCL updates
Amended bylaws include enhanced advance notice requirements for stockholder nominations, requiring detailed disclosures about nominees and proponents.
eHealth appoints John Stelben as CFO; reaffirms FY2022 guidance
John Stelben appointed CFO effective Nov 14, 2022, succeeding Christine Janofsky who was terminated Nov 11.
eHealth Q3 revenue $53.4M, net loss $39.1M; cost savings on track to exceed $90M in 2022
Total revenue $53.4M; GAAP net loss $39.1M; adjusted EBITDA loss $33.1M.
eHealth amends 2021 Inducement Plan, increases share reserve to 2.41M from 910K
Board approved increase of maximum shares reserved from 910,000 to 2,410,000 under the inducement plan.
eHealth amends credit agreement to replace LIBOR with SOFR as reference rate
Amendment dated August 16, 2022 to $150M credit agreement originally dated February 28, 2022.
eHealth amends Q2 earnings release; corrects non-GAAP EPS to ($1.15) from ($1.18)
Corrected non-GAAP net loss per diluted share for Q2 2022 to ($1.15), up from originally reported ($1.18).
eHealth reports Q2 2022 revenue $50.4M, GAAP net loss $37.5M; Chief Digital Officer departs
Total revenue $50.4M, GAAP net loss $(37.5)M, adjusted EBITDA $(33.3)M; includes $8.7M negative revenue adjustment.
eHealth shareholders approve 3M share increase to 2014 equity plan
Plan amendment increases maximum shares issuable by 3,000,000; voted For 16.18M vs Against 6.36M (excl. broker non-votes).
eHealth appoints John Dolan as chief accounting officer
John Dolan named CAO, effective May 31, 2022; Christine Janofsky remains CFO.
eHealth Q1 revenue falls 22% to $105.3M, GAAP net loss $32.7M, adjusted EBITDA loss $24.8M
Total revenue $105.3M, down 22% YoY from $134.2M.
eHealth increases 2021 inducement plan share reserve from 410,000 to 910,000
Board approved amendment to 2021 Inducement Plan on March 17, 2022.
eHealth corrects 2022 GAAP net loss guidance to narrower range of $106M-$83M loss
Corrected 2022 GAAP net loss guidance from $147M-$124M loss to $106M-$83M loss.
eHealth Q4 2021 revenue falls 17% to $243.5M, posts net loss of $32.2M; begins cost transformation
Revenue $243.5M ( -17% YoY ), GAAP net loss $32.2M vs prior year income.
eHealth appoints Roman Rariy as COO and Chief Transformation Officer effective March 1, 2022
Rariy previously at Lionbridge and Kraft Heinz; will lead cost transformation and operational excellence.
eHealth closes $70M secured term loan with Blue Torch Finance, replaces RBC facility
$70M secured term loan facility maturing Feb 28, 2025; LIBOR + 7.50% or Base Rate + 6.50%.
eHealth terminates CRO Timothy Hannan; appoints Robert Hurley as interim chief revenue officer
Timothy C. Hannan terminated as chief revenue officer effective January 31, 2022; no disagreement on company operations, policies or practices.
On May 3, 2026, Cesar Soriano notified the board of directors of eHealth, Inc. (the “Board”) of his decision to resign from the Board, including all committees thereof, effective immediately prior to the commencement of the Company’s 2026 Annual Meeting of Stockholders currently scheduled for June 18, 2026, at 9:00 a.m. Eastern Time.
Mr. Soistman has agreed to continue serving as chief executive officer and all other roles with its subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the “CEO Transition” and such period, the “Additional CEO Period”), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the “Transition Period”).
On September 21, 2024, the Board of Directors (the “Board”) of eHealth, Inc. (the “Company”) appointed Prama Bhatt as a member of the Board, effective as of September 24, 2024.
On August 6, 2024, Fran Soistman notified the Company of his decision to retire from his position as the Company’s chief executive officer upon appointment of a successor, which is expected to occur by or before the end of the second quarter of 2025.
John Dolan, age 56, who has served as the Company’s senior vice president, chief accounting officer since May 2022, will succeed Mr. Stelben as the Company’s senior vice president, chief financial officer, effective August 31, 2024.
On May 29, 2024, John Stelben notified eHealth, Inc. (the “Company”) of his decision to resign from his position as the Company’s senior vice president, chief financial officer, effective August 30, 2024.
On November 20, 2023, Roman Rariy notified eHealth, Inc. (the "Company") of his decision to resign from his position as the Company’s chief operating officer and chief transformation officer, effective December 31, 2023.
On February 3, 2023, Randall S. Livingston, a director of eHealth, Inc. (the “Company”), notified the Company of his intention not to stand for re-election as a director of the Company upon the expiration of his current term at the Company’s 2023 Annual Meeting of Stockholders.
Effective November 14, 2022, John J. Stelben will join eHealth, Inc. (the “Company”) as its new senior vice president, chief financial officer of the Company.
On November 8, 2022, Ms. Janofsky's employment with the Company was terminated effective November 11, 2022.
On August 3, 2022, Phillip Morelock’s employment as Chief Digital Officer of eHealth, Inc. (the “Company”) ceased and he departed the Company.
On May 31, 2022, eHealth, Inc. (the “Company”) appointed John Dolan as chief accounting officer and principal accounting officer of the Company, effective May 31, 2022.
Max materiality 0.85 · Median 0.68 · Most common event earnings